Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Kyndryl Holdings Inc (KD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Kyndryl Holdings Inc — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while Kyndryl Holdings Inc trades at $11.83 (market cap $2.67B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 2.6× Kyndryl Holdings Inc's market cap, and Kyndryl Holdings Inc is more actively traded (3,966,787 versus 2,977,440). Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Kyndryl Holdings Inc for 36 Days on average.
| IONS | KD | |
|---|---|---|
Market Cap | $7.04B | $2.67B |
Volume | 2,977,440 | 3,966,787 |
Sector | Health | Technology |
52-Week High | $86.50 | $28.92 |
52-Week Low | $42.38 | $10.59 |
Typical Hold Time | 0 Days | 36 Days |
Enterprise Value | $6.60B | $5.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Kyndryl (KD) trades at $11.79, up slightly by 0.08% with neutral technical indicators. The company shows improving fundamentals with 2025 revenue of $15.06B and a return to profitability with $252M net income after three years of losses. Recent earnings have been mixed with two misses and one beat. Analyst consensus is cautious with 71% hold ratings, though the $14.67 price target suggests 24% upside potential from current levels.
The stock presents a turnaround story with improving cash flow and profitability, but faces execution risks amid competitive pressures. Recent AI-focused initiatives and government contracts provide growth catalysts, though the high P/E ratio of 33.08 requires strong earnings growth to justify valuation. Institutional ownership trends and technical resistance near $12 remain key watchpoints.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Kyndryl Holdings Inc
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →
